Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BGB-11417 Cause Sepsis? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Sepsis have been filed in association with BGB-11417. This represents 4.1% of all adverse event reports for BGB-11417.

5
Reports of Sepsis with BGB-11417
4.1%
of all BGB-11417 reports
4
Deaths
4
Hospitalizations

How Dangerous Is Sepsis From BGB-11417?

Of the 5 reports, 4 (80.0%) resulted in death, 4 (80.0%) required hospitalization, and 2 (40.0%) were considered life-threatening.

Is Sepsis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BGB-11417. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does BGB-11417 Cause?

Febrile neutropenia (16) Death (10) Neutropenic sepsis (10) Acute myeloid leukaemia (9) Pneumonia (7) Off label use (6) Covid-19 (5) Pyrexia (5)

What Other Drugs Cause Sepsis?

RITUXIMAB (4,043) CYCLOPHOSPHAMIDE (4,041) METHOTREXATE (3,933) ADALIMUMAB (3,169) DEXAMETHASONE (3,150) LENALIDOMIDE (2,956) VINCRISTINE (2,791) DOXORUBICIN (2,740) PREDNISONE (2,634) PREDNISOLONE (2,281)

Which BGB-11417 Alternatives Have Lower Sepsis Risk?

BGB-11417 vs BICALUTAMIDE BGB-11417 vs BICTEGRAVIR BGB-11417 vs BICTEGRAVIR\EMTRICITABINE\TENOFOVIR ALAFENAMIDE BGB-11417 vs BIFIDOBACTERIUM LONGUM BGB-11417 vs BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS

Related Pages

BGB-11417 Full Profile All Sepsis Reports All Drugs Causing Sepsis BGB-11417 Demographics